Projected Income Statement: Albemarle Corporation

Forecast Balance Sheet: Albemarle Corporation

Forecast Balance Sheet - Albemarle Corporation
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 1,955 1,718 3,277 2,324 1,576 717 -177 -1,040
Change - -12.12% 90.75% -29.08% -32.19% -54.49% -124.69% -487.57%
Announcement Date 16/2/22 15/2/23 14/2/24 12/2/25 11/2/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Albemarle Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 953.7 1,262 2,149 1,686 589.8 513.1 626.5 707.7
Change - 32.29% 70.36% -21.56% -65.01% -13.01% 22.1% 12.96%
Free Cash Flow (FCF) 1 -609.4 646.2 -824 -983.7 692.5 1,300 1,272 1,125
Change - 206.04% -227.51% -19.39% 170.39% 87.66% -2.11% -11.56%
Announcement Date 16/2/22 15/2/23 14/2/24 12/2/25 11/2/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Albemarle Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 26.17% 47.48% 35.05% 21.2% 21.35% 43.99% 42.64% 40.75%
EBIT Margin (%) 18.54% 43.37% 30.57% 10.25% 8.54% 24.56% 25.62% 27.64%
EBT Margin (%) 4.02% 33.24% 2.57% -32.8% -10.74% 16.72% 19.71% 25.56%
Net margin (%) 3.72% 36.75% 16.36% -24.47% -13.17% 20.33% 25.08% 30.99%
FCF margin (%) -18.31% 8.83% -8.57% -18.29% 13.46% 21.39% 20.62% 17.57%
FCF / Net Income (%) -492.76% 24.02% -52.37% 74.75% -102.23% 105.26% 82.22% 56.69%

Profitability

        
ROA 4.39% 19.57% 15.54% -1.58% -0.56% 8.73% 9.52% 11.64%
ROE 8.31% 19.01% 30.12% -2.84% -0.95% 14.16% 12.64% 12.03%

Financial Health

        
Leverage (Debt/EBITDA) 2.24x 0.49x 0.97x 2.04x 1.43x 0.27x - -
Debt / Free cash flow -3.21x 2.66x -3.98x -2.36x 2.28x 0.55x - -

Capital Intensity

        
CAPEX / Current Assets (%) 28.66% 17.24% 22.35% 31.35% 11.47% 8.45% 10.16% 11.05%
CAPEX / EBITDA (%) 109.49% 36.3% 63.77% 147.91% 53.72% 19.2% 23.82% 27.12%
CAPEX / FCF (%) -156.49% 195.24% -260.85% -171.37% 85.17% 39.48% 49.25% 62.9%

Items per share

        
Cash flow per share 1 2.972 16.2 11.25 5.974 10.9 13.81 12.19 14.05
Change - 445.01% -30.52% -46.91% 82.41% 26.7% -11.72% 15.28%
Dividend per Share 1 1.56 1.58 1.6 1.61 1.62 1.616 1.648 1.664
Change - 1.28% 1.27% 0.63% 0.62% -0.25% 2% 0.94%
Book Value Per Share 1 48.07 67.77 80.17 84.74 80.99 83.92 88.01 101.1
Change - 40.97% 18.3% 5.69% -4.43% 3.62% 4.88% 14.85%
EPS 1 1.06 22.84 13.36 -11.2 -5.76 9.613 10.69 14.5
Change - 2,054.72% -41.51% -183.83% 48.57% 266.89% 11.15% 35.71%
Nbr of stocks (in thousands) 116,976 117,153 117,353 117,540 117,698 118,005 118,005 118,005
Announcement Date 16/2/22 15/2/23 14/2/24 12/2/25 11/2/26 - - -
1USD
Estimates
2026 *2027 *
P/E 10.1x 9.07x
PBR 1.16x 1.1x
EV / Sales 2x 1.83x
Yield 1.67% 1.7%

EPS & Dividend

EPS & Dividend - Albemarle Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - Albemarle Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Albemarle Corporation
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Albemarle Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
96.96USD
Average target price
156.35USD
Spread / Average Target
+61.25%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Albemarle Corporation
  1. Stock Market
  2. Stocks
  3. ALB Stock
  4. Financials Albemarle Corporation